These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 33967773)

  • 61. Neurologic Compromise in COVID-19: A Literature Review.
    Jardim Vaz de Mello L; Guimaraes Silva E; Oliveira Correa Rabelo G; Evaristo Leite M; Vieira NR; Bahadori M; Seifi A; Godoy DA
    J Neurol Res; 2020 Oct; 10(5):164-172. PubMed ID: 33984100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies.
    Dai XC; An ZY; Wang ZY; Wang ZZ; Wang YR
    Front Cardiovasc Med; 2021; 8():609857. PubMed ID: 33981731
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experience with the use of siltuximab in patients with SARS-CoV-2 infection.
    Meira F; Albiach L; Carbonell C; Martín-Oterino JA; Martín-Ordiales M; Linares L; Macaya I; Agüero D; Ambrosioni J; Bodro M; Cardozo C; Chumbita M; De la Mora M; García-Pouton N; Garcia-Vidal C; González-Cordón A; Hernández-Meneses M; Inciarte A; Laguno M; Leal L; Morata L; Puerta-Alcalde P; Rico V; Letona L; Cózar-Llistó A; Dueñas G; Solá M; Torres B; Rojas J; Moreno A; Moreno-García E; Torres M; Martínez JA; Soriano A; García F
    Rev Esp Quimioter; 2021 Aug; 34(4):337-341. PubMed ID: 33982984
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
    Garrett ME; Galloway J; Chu HY; Itell HL; Stoddard CI; Wolf CR; Logue JK; McDonald D; Weight H; Matsen FA; Overbaugh J
    Cell; 2021 May; 184(11):2927-2938.e11. PubMed ID: 34010620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.
    Lachance O; Goyer F; Adhikari NKJ; Masse MH; Bilodeau JF; Lamontagne F; Leclair MA
    J Med Case Rep; 2021 May; 15(1):297. PubMed ID: 34020705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohort.
    Comparon C; Boubaya M; Sritharan N; Dournon N; Duchemann B; Tine S; Lopez-Sublet M; Mongin M; Giroux-Leprieur B; Bloch-Queyrat C; Sigaux J; Cohen Y; Bohelay G; Caux F; Bihan H; Le Jeune S; Abad S; Levy V; Dhote R;
    Infect Dis (Lond); 2021 Oct; 53(10):779-788. PubMed ID: 34024240
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lactoferrin: a potential candidate to fight respiratory infections in the pandemic COVID-19 era.
    Passali D; Damiani V; Cianfrone F; Passali GC; Bellussi LM; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(1 Suppl. 2):9-13. PubMed ID: 33982532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes.
    Bychinin MV; Klypa TV; Mandel IA; Andreichenko SA; Baklaushev VP; Yusubalieva GM; Kolyshkina NA; Troitsky AV
    J Nutr; 2021 Aug; 151(8):2199-2205. PubMed ID: 33982128
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
    O'Donnell MR; Grinsztejn B; Cummings MJ; Justman JE; Lamb MR; Eckhardt CM; Philip NM; Cheung YK; Gupta V; João E; Pilotto JH; Diniz MP; Cardoso SW; Abrams D; Rajagopalan KN; Borden SE; Wolf A; Sidi LC; Vizzoni A; Veloso VG; Bitan ZC; Scotto DE; Meyer BJ; Jacobson SD; Kantor A; Mishra N; Chauhan LV; Stone EF; Dei Zotti F; La Carpia F; Hudson KE; Ferrara SA; Schwartz J; Stotler BA; Lin WW; Wontakal SN; Shaz B; Briese T; Hod EA; Spitalnik SL; Eisenberger A; Lipkin WI
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33974559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.
    Drake TM; Fairfield CJ; Pius R; Knight SR; Norman L; Girvan M; Hardwick HE; Docherty AB; Thwaites RS; Openshaw PJM; Baillie JK; Harrison EM; Semple MG;
    Lancet Rheumatol; 2021 Jul; 3(7):e498-e506. PubMed ID: 33997800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An examination of sedation requirements and practices for mechanically ventilated critically ill patients with COVID-19.
    Balakrishna A; Walsh EC; Hamidi A; Berg S; Austin D; Pino RM; Hanidziar D; Chang MG; Bittner EA
    Am J Health Syst Pharm; 2021 Oct; 78(21):1952-1961. PubMed ID: 33993212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
    Greenbaum U; Klein K; Martinez F; Song J; Thall PF; Ramdial JL; Knape C; Aung FM; Scroggins J; Knopfelmacher A; Mulanovich V; Borjan J; Adachi J; Muthu M; Leung C; Medina MC; Champlin R; Olson A; Alousi A; Rezvani K; Shpall EJ
    Front Immunol; 2021; 12():675679. PubMed ID: 33995420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up.
    Gamberini L; Mazzoli CA; Sintonen H; Colombo D; Scaramuzzo G; Allegri D; Tonetti T; Zani G; Capozzi C; Giampalma E; Agnoletti V; Becherucci F; Bertellini E; Castelli A; Cappellini I; Cavalli I; Crimaldi F; Damiani F; Fusari M; Gordini G; Laici C; Lanza MC; Leo M; Marudi A; Nardi G; Ottaviani I; Papa R; Potalivo A; Ranieri VM; Russo E; Taddei S; Volta CA; Spadaro S;
    Qual Life Res; 2021 Oct; 30(10):2805-2817. PubMed ID: 33977415
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
    Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
    Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019.
    Shabani M; Sadegh Ehdaei B; Fathi F; Dowran R
    New Microbes New Infect; 2021 Jul; 42():100895. PubMed ID: 33976895
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhaled budesonide for early treatment of COVID-19.
    San-Juan R; Fernández-Ruiz M; López-Medrano F; Aguado JM
    Lancet Respir Med; 2021 Jul; 9(7):e58. PubMed ID: 33991508
    [No Abstract]   [Full Text] [Related]  

  • 77. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
    Dispinseri S; Secchi M; Pirillo MF; Tolazzi M; Borghi M; Brigatti C; De Angelis ML; Baratella M; Bazzigaluppi E; Venturi G; Sironi F; Canitano A; Marzinotto I; Tresoldi C; Ciceri F; Piemonti L; Negri D; Cara A; Lampasona V; Scarlatti G
    Nat Commun; 2021 May; 12(1):2670. PubMed ID: 33976165
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
    Deng X; Garcia-Knight MA; Khalid MM; Servellita V; Wang C; Morris MK; Sotomayor-González A; Glasner DR; Reyes KR; Gliwa AS; Reddy NP; Sanchez San Martin C; Federman S; Cheng J; Balcerek J; Taylor J; Streithorst JA; Miller S; Sreekumar B; Chen PY; Schulze-Gahmen U; Taha TY; Hayashi JM; Simoneau CR; Kumar GR; McMahon S; Lidsky PV; Xiao Y; Hemarajata P; Green NM; Espinosa A; Kath C; Haw M; Bell J; Hacker JK; Hanson C; Wadford DA; Anaya C; Ferguson D; Frankino PA; Shivram H; Lareau LF; Wyman SK; Ott M; Andino R; Chiu CY
    Cell; 2021 Jun; 184(13):3426-3437.e8. PubMed ID: 33991487
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diverse functional autoantibodies in patients with COVID-19.
    Wang EY; Mao T; Klein J; Dai Y; Huck JD; Jaycox JR; Liu F; Zhou T; Israelow B; Wong P; Coppi A; Lucas C; Silva J; Oh JE; Song E; Perotti ES; Zheng NS; Fischer S; Campbell M; Fournier JB; Wyllie AL; Vogels CBF; Ott IM; Kalinich CC; Petrone ME; Watkins AE; ; Dela Cruz C; Farhadian SF; Schulz WL; Ma S; Grubaugh ND; Ko AI; Iwasaki A; Ring AM
    Nature; 2021 Jul; 595(7866):283-288. PubMed ID: 34010947
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia.
    Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A
    Br J Clin Pharmacol; 2021 Dec; 87(12):4861-4867. PubMed ID: 33990984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.